Metabolomic Logic Behind MAT2A/PRMT5 Combinations
Two Targets, One Pathway: The Metabolomic Logic Behind MAT2A/PRMT5 Combination Therapies The next breakthrough in cancer treatment may come from attacking two targets within the same metabolic pathway. MAT2A and PRMT5 inhibitor combinations represent a new paradigm in...
Beyond Trial and Error: Multi-Omics for Cultured Meat Media Optimization
The Traditional Media Optimization Bottleneck If you’re developing cultured meat at scale, you know the frustration. Your cells grow well for the first 48-72 hours, then productivity crashes. You suspect the media formulation, but identifying the limiting...
Imaging and Metabolomics in Radioligand Therapy
Connecting the Two Halves of the RLT Puzzle Understanding how radioligand therapy (RLT) works in cell line-derived xenograft (CDX) models requires connecting two complementary perspectives: Where the treatment goes, and What happens inside tumor cells once it gets...